Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Enzymatica AB

Market Cap 612M 533M 491M 462M 865M 57.65B 871M 5.85B 2.27B 28.41B 2.3B 2.25B 98.47B P/E 2024
-5.73x
P/E 2025 -8.89x
Enterprise Value 580M 505M 466M 438M 819M 54.62B 825M 5.54B 2.15B 26.92B 2.18B 2.13B 93.3B EV / Sales 2024
5.88x
EV / Sales 2025 7.96x
Free-Float
56.66%
Yield 2024 *
-
Yield 2025 -
1 day+0.80%
Current month-7.69%
1 month+1.61%
3 months+12.50%
6 months+42.78%
Current year+32.63%
1 week 2.41
Extreme 2.41
2.6
1 month 2.3
Extreme 2.3
2.93
Current year 1.6
Extreme 1.6
3.4
1 year 1.6
Extreme 1.6
3.4
3 years 1.34
Extreme 1.34
5.45
5 years 1.34
Extreme 1.34
13.4
10 years 1.34
Extreme 1.34
24.7
Manager TitleAgeSince
Chief Executive Officer - 01/02/2026
Chief Operating Officer 61 01/01/2011
Director of Finance/CFO - 13/04/2026
Director TitleAgeSince
Chairman 58 15/02/2016
Chairman 64 19/12/2016
Director/Board Member 71 19/12/2016
Date Insider Type Main position Quantity % Market Cap.
04-01Sell

Responsable ventes & marketing

40,000 0.0165%
12-30Buy

Chairman

20,000 0.0082%
12-27Buy

Chairman

20,000 0.0082%
Change 5-day change 1-year change 3-year change Capi.($)
+0.80%0.00%-12.80%-6.67% 64.01M
+32.62%-5.37%+39.94%+145.38% 980B
-3.20%-4.17%+51.52%+39.07% 550B
-2.14%-3.68%+16.71%+56.15% 382B
-2.39%+0.25%+25.86%+16.53% 317B
+0.26%-1.66%+25.45%+13.67% 270B
+0.52%-2.49%+25.03%+31.03% 269B
+4.61%+2.30%-39.83%-45.72% 191B
-1.90%-4.65%+16.56%+47.00% 182B
-1.35%-1.68%+14.59%+56.94% 154B
Average -0.45%-2.41%+16.30%+35.34% 329.41B
Weighted average by Cap. -1.05%-3.38%+28.33%+64.13%

Financials

2024 2025
Net sales 45.58M 39.71M 36.61M 34.43M 64.41M 4.3B 64.87M 436M 169M 2.12B 171M 167M 7.34B 53.9M 46.97M 43.29M 40.72M 76.18M 5.08B 76.72M 515M 200M 2.5B 202M 198M 8.68B
Net income -53.18M -46.33M -42.71M -40.18M -75.16M -5.01B -75.69M -508M -197M -2.47B -200M -195M -8.56B -51.89M -45.21M -41.68M -39.2M -73.34M -4.89B -73.86M -496M -193M -2.41B -195M -191M -8.35B
Net Debt -73.01M -63.61M -58.64M -55.16M -103M -6.88B -104M -698M -271M -3.39B -274M -268M -11.75B -32.11M -27.98M -25.79M -24.26M -45.38M -3.03B -45.7M -307M -119M -1.49B -121M -118M -5.17B
Logo Enzymatica AB
Enzymatica AB (publ) is a Sweden-based life science company that develops and sells medical devices for infection-related diseases. The Company deals with research, development and sales of products based on enzyme technology and related activities. Enzymatica AB (publ) develops solutions that support the body's own defenses against virus, irritants and microorganisms. The Company offers products which are based on a barrier technology, includes marine enzymes. Enzymatica AB (publ) focuses on product development based on the tested and patented barrier technology used in the common cold product ColdZyme, a mouth spray that protects against colds, can help shorten the duration of the cold if used in the early stages of infection, relieves cold symptoms, and soothes sore throats.
Employees
21
Date Price Change Volume
18/06/26 2.520 kr +0.80% 125,420
17/06/26 2.500 kr -0.40% 43,593
16/06/26 2.510 kr -3.46% 84,343
15/06/26 2.600 kr +3.17% 57,127
12/06/26 2.520 kr 0.00% 14,793

Net sales - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ENZY Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!